Clinical context
Depression treatment should be matched to severity, duration, previous response, functional difficulties, and preference. NICE’s adult guideline includes structured CBT and behavioural activation among several options; guided self-help includes practitioner support rather than simply providing materials. Its chronic-symptom pathway also addresses social and vocational needs. This broader framework matters because a thought record is one possible tool within care, not a complete account of why someone is depressed or what support they need (National Institute for Health and Care Excellence [NICE], 2022).
Sources: NICE, 2022
Evidence and comparison
Cuijpers et al. (2023) synthesized 409 trials across ages and settings. CBT reduced symptoms more than pooled controls, including usual care and waitlist, with g=0.79 (95% CI 0.70–0.89). The advantage over other psychotherapies was small and unstable in sensitivity analyses. High heterogeneity, risk of bias, and publication bias limit a single headline effect. Benefits persisted against controls through 6–12 months; this is not a guarantee of permanent recovery. Because the review includes younger participants and several settings, the whole sample must not be relabeled adult outpatient evidence.
Sources: Cuijpers et al., 2023
Why the care setting matters
A 2025 primary-care review pooled CBT, cognitive therapy, and behavioural activation across 44 studies. Benefits appeared against inactive controls, but there was no detected advantage over active treatments; most studies had high risk of bias. The narrower result reinforces the importance of setting and comparator. It does not overturn the broader evidence or prove that all alternatives are equivalent (Carey et al., 2025).
Sources: Carey et al., 2025
What component research contributes
The COBRA trial compared full courses of behavioural activation and CBT in 440 adults. At 12 months, behavioural activation met its prespecified noninferiority criterion. Both interventions involved trained practitioners and supervision; neither was a stand-alone prompt sequence. The finding supports investigating practical behavioural components and workforce models, rather than attributing every improvement to cognitive restructuring or concluding that any activity tracker constitutes depression therapy (Richards et al., 2016).
Sources: Richards et al., 2016
Persistent symptoms and applicability
A separate trial in 268 medication-free adults with early-onset chronic depression found a modest advantage for the Cognitive Behavioral Analysis System of Psychotherapy over supportive psychotherapy. CBASP is a specialized interpersonal-behavioural treatment, and its comparison does not establish that generic CBT prompts work equally well for persistent depression. The 48-week results included continued treatment; they should not be described as benefits maintained for a year after treatment stopped (Schramm et al., 2017).
Sources: Schramm et al., 2017
Digital self-help and open questions
CBT can help with depressive symptoms and forms part of several evidence-based care pathways. That conclusion concerns tested interventions; it does not provide an outcome estimate for Umbrella Journal, Ella, or Nuggets. A useful next research step is to compare a specified digital tool with a credible alternative and assess functioning, symptom change, deterioration, and follow-up among participants who stop using it. Persistent symptoms and initial severity need separate attention. These are research questions, not studies already completed by the company.
Sources: Cuijpers et al., 2023; NICE, 2022; Richards et al., 2016; Schramm et al., 2017
References
Links open the original papers or official sources. Access labels describe the material assessed for this review.
National Institute for Health and Care Excellence (2022). Depression in adults: Treatment and management. NICE guideline NG222.
Access assessed: official indexed recommendation excerpts; direct HTML 403
Cuijpers, P., Miguel, C., Harrer, M., Plessen, C. Y., Ciharova, M., Ebert, D., & Karyotaki, E. (2023). Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: A comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry, 22(1), 105–115. 10.1002/wps.21069
Access assessed: full text, publisher
Carey, M., Kerr-Gaffney, J., Strawbridge, R., Hieronymus, F., McCutcheon, R. A., Young, A. H., & Jauhar, S. (2025). Are cognitive behavioural therapy, cognitive therapy, and behavioural activation for depression effective in primary care? A systematic review and meta-analysis. Journal of Affective Disorders, 382, 215–226. 10.1016/j.jad.2025.04.070
Access assessed: PubMed abstract, metadata and disclosures
Richards, D. A., Ekers, D., McMillan, D., Taylor, R. S., Byford, S., Warren, F. C., Barrett, B., Farrand, P. A., Gilbody, S., Kuyken, W., O’Mahen, H., Watkins, E. R., Wright, K. A., Hollon, S. D., Reed, N., Rhodes, S., Fletcher, E., & Finning, K. (2016). Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): A randomised, controlled, non-inferiority trial. The Lancet, 388(10047), 871–880. 10.1016/S0140-6736(16)31140-0
Access assessed: published full-text PDF, institutional repository
Schramm, E., Kriston, L., Zobel, I., Bailer, J., Wambach, K., Backenstrass, M., Klein, J. P., Schoepf, D., Schnell, K., Gumz, A., Bausch, P., Fangmeier, T., Meister, R., Berger, M., Hautzinger, M., & Härter, M. (2017). Effect of disorder-specific vs nonspecific psychotherapy for chronic depression: A randomized clinical trial. JAMA Psychiatry, 74(3), 233–242. 10.1001/jamapsychiatry.2016.3880
Access assessed: full text, publisher
This evidence review is educational. It does not provide an individual diagnosis or treatment plan. Read the review methods, access limits, and clinical-review status.